P61 Health State Utility Values and Quality of Life in Patients Receiving Ripretinib in the Phase 3 Invictus Trial and a Real-World Evidence Study in ChinaR. L. Jones,J. Y. Blay,P. Chi,S. Bauer,H. Gelderblom,L. Shen,Y. L. He,M. C. Heinrich,P. Schoffski,J. R. Zalcberg,B. Harrow,M. L. Sherman,R. Ruiz-Soto,C. Becker,M. von MehrenValue in Health（2022）引用 0|浏览15AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
